ConductScience.org, home

Paper19740904

Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.

Lie E and 8 others. Ann Rheum Dis, 2010. Cited by 95 papers, by iCite.

Cite this record

ConductScience Library. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis. Papers, record 19740904. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19740904

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
PubMed
Journal
Ann Rheum Dis
PubMed
Year
2010
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
95
iCite
Relative citation ratio, by iCite
2.96
iCite
Revised in PubMed
2026-01-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lie EElisabeth
2van der Heijde DDésirée
3Uhlig TTill
4Heiberg MSMarte S
5Koldingsnes WWenche
6Rødevand EErik
7Kaufmann CCecilie
8Mikkelsen KKnut
9Kvien TKTore K

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antirheumatic AgentsMajor topic
Arthritis, PsoriaticMajor topic
Arthritis, RheumatoidMajor topic
Immunosuppressive AgentsMajor topic
MethotrexateMajor topic
Adult
Aged
Drug Administration Schedule
Epidemiologic Methods
Female
Humans
Male
Middle Aged
Patient Dropouts
Quality of Life
Treatment Outcome
Drug Monitoring

Source PubMed

Download CSV of topics

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMIDTitleJournalYearIn PapersSource
40768107Suboptimal methotrexate utilization in Chinese patients with inflammatory arthritis: data from a Chinese center.Clin Rheumatol2025https://conductscience.org/library/papers/40768107PubMed
39768461Long-Term Survival of Methotrexate as First-Line Therapy in Rheumatoid Arthritis, Psoriatic Arthritis and Undifferentiated Arthritis.J Clin Med2024https://conductscience.org/library/papers/39768461PubMed
38922101Inflammatory Bowel Disease Therapies and Acute Liver Injury.Toxics2024https://conductscience.org/library/papers/38922101PubMed
37210684Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus.Dermatol Ther (Heidelb)2023https://conductscience.org/library/papers/37210684PubMed
37173095Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study.RMD Open2023https://conductscience.org/library/papers/37173095PubMed
36933068Long-term persistence of oral methotrexate and associated factors in rheumatoid arthritis: a retrospective cohort study.Rheumatol Int2023https://conductscience.org/library/papers/36933068PubMed
35971643Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis.ACR Open Rheumatol2022https://conductscience.org/library/papers/35971643PubMed
35734243Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database.Open Access Rheumatol2022https://conductscience.org/library/papers/35734243PubMed
35464810Is there still a place for methotrexate in severe psoriatic arthritis?Ther Adv Musculoskelet Dis2022https://conductscience.org/library/papers/35464810PubMed
35005587Non-adherence and discontinuation rate for oral and parenteral methotrexate: A retrospective-cohort study in 8,952 patients with psoriatic arthritis.J Transl Autoimmun2021https://conductscience.org/library/papers/35005587PubMed
34881269Patients With IBD Receiving Methotrexate Are at Higher Risk of Liver Injury Compared With Patients With Non-IBD Diseases: A Meta-Analysis and Systematic Review.Front Med (Lausanne)2021https://conductscience.org/library/papers/34881269PubMed
34684087Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis.Medicina (Kaunas)2021https://conductscience.org/library/papers/34684087PubMed
33796242
Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study.
Ther Adv Chronic Dis2021https://conductscience.org/library/papers/33796242PubMed
32734482Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis.Rheumatol Ther2020https://conductscience.org/library/papers/32734482PubMed
32434812EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.Ann Rheum Dis2020https://conductscience.org/library/papers/32434812PubMed
31777840Real-World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid Arthritis.ACR Open Rheumatol2019https://conductscience.org/library/papers/31777840PubMed
31522319Clinico-genetic model to predict methotrexate intolerance in rheumatoid arthritis.Clin Rheumatol2020https://conductscience.org/library/papers/31522319PubMed
31474599Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.J Rheumatol2020https://conductscience.org/library/papers/31474599PubMed
30816631SEAM-PsA: Seems Like Methotrexate Works in Psoriatic Arthritis?Arthritis Rheumatol2019https://conductscience.org/library/papers/30816631PubMed
30713716Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study.RMD Open2019https://conductscience.org/library/papers/30713716PubMed

See all 39 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19740904

GET https://conductscience.org/api/papers/v1/19740904/cited_by?page=2